This company has been marked as potentially delisted and may not be actively trading. NASDAQ:BASI Bioanalytical Systems (BASI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Bioanalytical Systems Stock (NASDAQ:BASI) 30 days 90 days 365 days Advanced Chart Remove Ads Get Bioanalytical Systems alerts:Sign Up Key Stats Today's Range$2.35▼$2.8150-Day Range$14.04▼$22.5052-Week Range$3.05▼$21.08Volume663,407 shsAverage Volume122,925 shsMarket Capitalization$30.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.Read More… Remove Ads Receive BASI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioanalytical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address BASI Stock News HeadlinesSapio Sciences enhances lab informatics platform with new immunogenicity bioanalysis featuresOctober 18, 2024 | msn.comWhat a Basic Metabolic Panel (BMP) MeasuresApril 29, 2024 | yahoo.comThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.April 4, 2025 | Timothy Sykes (Ad)10 Analysts Assess NIO: What You Need To KnowApril 2, 2024 | markets.businessinsider.comWhat Is Bioprocessing? Here Are the BasicsMarch 27, 2024 | msn.comWhat 11 Analyst Ratings Have To Say About Analog DevicesFebruary 12, 2024 | markets.businessinsider.comDemystifying Airbnb: Insights From 13 Analyst ReviewsJanuary 29, 2024 | markets.businessinsider.com7 Best B2B Database Providers for 2024January 26, 2024 | techrepublic.comSee More Headlines BASI Stock Analysis - Frequently Asked Questions How were Bioanalytical Systems' earnings last quarter? Bioanalytical Systems, Inc. (NASDAQ:BASI) announced its quarterly earnings results on Monday, February, 8th. The company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.16. The business had revenue of $17.89 million for the quarter. Bioanalytical Systems had a negative trailing twelve-month return on equity of 42.74% and a negative net margin of 7.75%. Read the conference call transcript. What other stocks do shareholders of Bioanalytical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioanalytical Systems investors own include Meta Platforms (META), Enphase Energy (ENPH), Overstock.com (OSTK), Riot Platforms (RIOT), Twilio (TWLO), Boeing (BA) and NVIDIA (NVDA). Company Calendar Last Earnings2/08/2021Today4/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:BASI CIK720154 Webwww.basinc.com Phone765-463-4527FaxN/AEmployees397Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,680,000.00 Net Margins-7.75% Pretax MarginN/A Return on Equity-42.74% Return on Assets-6.38% Debt Debt-to-Equity Ratio2.49 Current Ratio0.48 Quick Ratio0.46 Sales & Book Value Annual Sales$60.47 million Price / Sales0.51 Cash Flow$0.00 per share Price / Cash Flow558.40 Book Value$0.69 per share Price / Book4.00Miscellaneous Outstanding Shares11,131,000Free FloatN/AMarket Cap$30.72 million OptionableNot Optionable Beta1.92 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:BASI) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.